Incendia Therapeutics’ Post

Thoughts on this? >> Coherus lays off 30% of staff following Cimerli sale to Sandoz >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharmaceutical #pharma #biotech

Thoughts on this? >> Coherus lays off 30% of staff following Cimerli sale to Sandoz >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #pharmaceutical #productmarketing #healthcare

🔔 It was a less severe month in terms of Layoffs in December with just 13 companies affected. Also worth noting the number of employees affected in a lot of cases was not as substantial. See details below..... ❌ Axcella [SHUTDOWN operations] ❌ Orna Therapeutics [undisclosed] ❌ Travere Therapeutics [20%] ❌ ReNAgade Therapeutics [10%] ❌ IGM Biosciences [22%] ❌ Ventyx Biosciences [20%] ❌ Altamira Therapeutics [25%] ❌ Ferring Pharmaceuticals [134 jobs across NJ and MN sites] ❌ Vir Biotechnology [12%] ❌ Reneo Pharmaceuticals [70%] ❌ Asher Bio [60%] ❌ Aclaris Therapeutics [46%] ❌ Oxurion [~80%]

Thoughts on this? >> BioMarin confirms layoffs and R&D cuts - LabPulse >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #pharmaceutical #competitivemarketing

Thoughts on this? >> BioMarin confirms layoffs and R&D cuts - LabPulse >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #healthcare #pharma #pharmaceutical

Insider trading at Vera Therapeutics Inc. 🟢 Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. 🟢 Company priced its upsized public offering of 8,064,517 class common stock at $31 per share. 🟢 Director Maha Katabi invested $5 million to acquire a total of 161,290 shares at an average price of $31. 🟢 When insiders buy stock, it shows that they are optimistic about the company's future or that they think the price is cheap. In any case, this suggests a chance to buy the stock at a discount. 🟢 Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. 🟢For stock analysis and advice, join our free Telegram Channel or visit our website. Links are in the bio! Source: Benzinga #usnews #usstockmarket #usstockadvice #stockmarketadvisory #naranjcapitalusa #veratherapeutics #insidertrading

Pitching to investors soon? My top tips for #biotech and #biopharma execs based on my 16+ years in life science BD 👇 ✅Communicate the potential clinical impact and value. ✅Outline risks and risk mitigation strategies. ✅Set up a “data room” that includes information like asset characterization, preclinical data, clinical data (for late-stage therapeutics), correspondence with regulatory agencies, etc. ✅Build the ideal due diligence package checklist Want more strategic advice on how to nail your next pitch to #lifescience VCs and investors? Let’s schedule an exploratory call: https://buff.ly/3Kk7Xgu #investors #lifesciences #VCs #venturecapital #pitchdeck

The right adjective to use here is "Redesign". The article underscores the dynamic nature of the pharmaceutical industry and the imperative for companies to adapt swiftly to remain competitive and advance innovation. CEO Viehbacher's strategy emphasizes prioritizing key therapeutic areas while optimizing the company's organizational structure. This decision could impact both short-term financials and long-term growth prospects. #pharmaceuticalindustry #pharmaceutical #drugs #biogen

Thoughts on this? >> Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #productmarketing #pharmaceutical

What can you gain by trusting Hoeford Research with your preclinical testing? 🤔 Our outsourcing partner, Medicilon, has expertise in the development of small-molecule drugs, including PROTACs, ADCs and AOCs. This means that we can support your vision for these and other novel drug candidates, propelling early-stage drug discovery towards success. Our team understands the challenges of preclinical drug development and brings regulatory and project management expertise that gives you a strategic edge. Our comprehensive package covers: ➡️ Target identification ➡️ Lead discovery & optimisation ➡️ Safety assessment ➡️ Formulation development Work with us to design your unique testing package and reap the benefits of trusting us with your next drug candidate! 🔗 https://bit.ly/3TWWCXT #preclinicalresearch #drugcandidates #contracttesting